Multiple sclerosis: Geoepidemiology, genetics and the environment. Milo R, Kahana E. Autoimmunity Reviews, 2010. DOI:10.1016%2Fj.autrev.2009.11.010
Review of evaluation and p.i.d.o.r in prevalence by incidence. Jan Itor, Persival Cox et al. Scrubs, 2001. DOI:34k.19012/9i2ss5m4y4543a8ss
Multiple sclerosis – diagnosis, management and prognosis. Tsang BK, Macdonell R. Australian family physician, 2011. PMID:22146321
Limited impact of the summer heat wave in France (2003) on hospital admissions and relapses for multiple sclerosis. Tataru N, Vidal C et al. Neuroepidemiology, 2006. DOI:10.1159/000094233
Stress regulation in multiple sclerosis: current issues and concepts. Heesen C, Mohr DC et al. Multiple sclerosis, 2007. PMID:17439878
Modeling Uhthoff’s phenomenon in MS patients with internuclear ophthalmoparesis. Davis SL, Frohman TC. Neurology, 2008. PMID:18287569
Exercise and multiple sclerosis. White LJ, Dressendorfer RH. Sports medicine, 2004. PMID:15575796
Exercises for people with MS – index. Multiple Sclerosis Trust. https://www.mstrust.org.uk/understanding-ms/living-ms/lifestyle/exercise-and-ms/exercises-people-ms-index
Effect of precooling on physical performance in multiple sclerosis. White AT, Wilson TE. Multiple sclerosis, 2000. PMID:10871829
MS daily blog, experts & community. https://multiplesclerosis.net/
Multiple Sclerosis: Hope Through Research. NIH NINDS. http://www.ninds.nih.gov/disorders/multiple_sclerosis/detail_multiple_sclerosis.htm
The Lancet Core Clinical Collection: MS. DOI:10.1016/S0140–6736(08)61620–7
Defining the clinical course of multiple sclerosis. Lublin FD, Reingold SC. Neurology, 1996. PMID:8780061
History of Tobacco. Boston University MedicalCenter. http://academic.udayton.edu/health/syllabi/tobacco/history.htm
Smoking and Carcinoma of the Lung. Richard Doll and A. Bradford Hill. BMJ, 1950. PMC2038856
Tobacco Could Kill One Billion By 2100, WHO Report Warns. ScienceDaily, 2008. https://www.sciencedaily.com/releases/2008/02/080210092031.htm
Transdermal nicotine for mildly to moderately active ulcerative colitis. Sandborn WJ, Tremaine WJ et al. Annals of internal medicine, 1997. PMID:9054280
Effects of Tobacco Smoking & Nicotine on Cancer Treatment. Petros PW, Younis RI. Pharmacotherapy, 2013. PMC3499669
Long-term nicotine replacement therapy: cancer risk in context. Shields PG. Cancer prevention research, 2011. PMID:22052338
A reversible model of the cognitive impairment associated with schizophrenia in monkeys: Potential therapeutic effects of two nicotinic acetylcholine receptor agonists. Buccafuscoa JJ, Terry VA Jr. Biochemical Pharmacology, 2009. DOI:10.1016/j.bcp.2009.06.102
Desensitization of Nicotinic Acetylcholine Receptors as a Strategy for Drug Development. Buccafuscoa JJ, Beach WJ, Terry VA Jr. The journal of pharmacology and experimental therapeutics, 2009. DOI:10.1124/jpet.108.145292
Tobacco Smoke and Involuntary Smoking. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans 2004, vol. 83. http://own.0x3.ru/index.php/s/MNSq4cywFBACO5V
Philip Morris toxicological experiments with fresh sidestream smoke: more toxic than mainstream smoke. S Schick, S Glantz. Tobacco control, 2005. DOI:10.1136/tc.2005.011288
Secondhand smoke: facts and lies. Samet MS. Salud Publica Mex 2008. DOI:10.1590/S0036–36342008000500016
Methods for Quantification of Exposure to Cigarette Smoking and Environmental Tobacco Smoke: Focus on Developmental Toxicology. Florescu A, Ferrence R et al. Therapeutic Drug Monitoring, 2009. DOI:10.1097/FTD.0b013e3181957a3b
Respiratory Health Effects of Passive Smoking: Lung Cancer And Other Disorders. Office of Health and Environmental Assessment (OHEA), 1992. http://own.0x3.ru/index.php/s/onw2p7TEaV2WifG
E-cigarettes: Safe to recommend to patients? Jerry MJ, Collins BG, Streem D. Cleveland Clinic Journal of Medicine, 2015. DOI:10.3949/ccjm.82a.14054
Quitting Smoking Among Adults – United States, 2001–2010 – CDC. https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6044a2.htm
Strategies to Help a Smoker Who Is Struggling to Quit. Rigotti AN. JAMA. 2012. DOI:10.1001/jama.2012.13043
Reduction versus abrupt cessation in smokers who want to quit. Lindson-Hawley N, Aveyard P, Hughes RJ. Cochrane Tobacco Addiction Group, 2012. DOI:10.1002/14651858.CD008033.pub3
Competitions and incentives for smoking cessation. Cahill K, Perera R. Cochrane Tobacco Addiction Group, 2008. DOI:10.1002/14651858.CD004307.pub3
Self-help interventions for smoking cessation. Lancaster T, Stead FL. Cochrane Tobacco Addiction Group, 2005. DOI:10.1002/14651858.CD001118.pub2
Quit smoking @ Mayo clinic. http://www.mayoclinic.org/healthy-lifestyle/quit-smoking/in-depth/smoking-cessation/art-20045441?pg=2
The role of action planning and plan enactment for smoking cessation. De Vries H, Eggers SM, Bolman C. BMC Public Health 2013. DOI:10.1186/1471–2458–13–393
Major depression following smoking cessation. Covey SL, Glassman HA et al. American journal of psychiatry, 2006. DOI:10.1176/ajp.154.2.263
Smoking, Smoking Cessation, and Major Depression. Glassman HA, Helzer EJ et al. JAMA. 1990. DOI:10.1001/jama.1990.03450120058029
Change in anxiety following successful and unsuccessful attempts at smoking cessation: cohort study. McDermott SM, Marteau MT et al. The British Journal of Psychiatry Jan 2013. DOI:10.1192/bjp.bp.112.114389
Nicotine without smoke: Tobacco harm reduction. Royal college of physicians, 2016. https://www.rcplondon.ac.uk/projects/outputs/nicotine-without-smoke-tobacco-harm-reduction-0
E-cigarettes: an emerging public health consensus. Public Health England, 2015. https://www.gov.uk/government/news/e-cigarettes-an-emerging-public-health-consensus
E-cigarettes and smoking cessation in real-world and clinical settings: a systematic review and meta-analysis. Kalkhoran S, Glantz AS. The Lancet. Respiratory medicine. 2016. DOI:10.1016/S2213–2600(15)00521–4
21st-Century Hazards of Smoking and Benefits of Cessation in the United States. Jha P, Ramasundarahettige C et al. The New England Journal of Medicine, 2013. DOI:10.1056/NEJMsa1211128
Weight gain in smokers after quitting cigarettes: meta-analysis. Aubin H-J, Farley A et al. BMJ 2012. DOI:10.1136/bmj.e4439
Nicotinic Receptor-Mediated Effects on Appetite and Food Intake. Jo Y-H, Talmage AD et al. Journal of neurobiology, 2002. PMC2367209
Interventions for preventing weight gain after smoking cessation. Farley CA, Hajek P et al. Cochrane Tobacco Addiction Group, 2012. DOI:10.1002/14651858.CD006219.pub3
Quitting smoking: Still a challenge, but newer tools show promise. Collins BG, Jerry MJ, Bales R. Cleveland Clinic Journal of Medicine, 2015. DOI:10.3949/ccjm.81a.14016
Quitting Smoking – CDC. http://www.cdc.gov/tobacco/data_statistics/fact_sheets/cessation/quitting/
2014 Surgeon General’s Report: The Health Consequences of Smoking – 50 Years of Progress – CDC. http://www.cdc.gov/tobacco/data_statistics/sgr/50th-anniversary/index.htm
Helping a Smoker Quit: Do’s and Don’ts. General hints for friends and family. American cancer society. http://www.cancer.org/healthy/stayawayfromtobacco/helping-a-smoker-quit
Preliminary results of an examination of electronic cigarette user puff topography. Spindle TR, Breland AB et al. Nicotine & tobacco research, 2015. PMC4838000
Electronic cigarettes: review of use, content, safety, effects on smokers and potential for harm and benefit. Hajek P, Etter J-F et al. Addiction, 2014. DOI:10.1111/add.12659
Nicotine absorption from electronic cigarette use: comparison between first and new-generation devices. Farsalinos EK, Spyrou A et al. The Nature, 2014. DOI:10.1038/srep04133
E-cigarettes and Lung Health. American lung association, 2016. http://www.lung.org/stop-smoking/smoking-facts/e-cigarettes-and-lung-health.html
E-Cigarettes and Future Cigarette Use. Barrington-Trimis LJ, Urman R et al. Pediatrics, 2016. DOI:10.1542/peds.2016–0379
More than a quarter-million youth who had never smoked a cigarette used e-cigarettes in 2013 – CDC. http://www.cdc.gov/media/releases/2014/p0825-e-cigarettes.html
Peering through the mist: systematic review of what the chemistry of contaminants in electronic cigarettes tells us about health risks. Burtsyn I. BMC Public Health, 2014. DOI:10.1186/1471–2458–14–18
E-Cigarettes. A Scientific Review. Grana R, Benowitz N, Glantz AS. Circulation, 2014. DOI:10.1161/CIRCULATIONAHA.114.007667
Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarette substitutes: a systematic review. Farsalinos EK. Therapeutics advances in drug safety, 2014. DOI:10.1177/2042098614524430
Are Metals Emitted from Electronic Cigarettes a Reason for Health Concern? Farsalinos EK, Voudris V, Poulas K. International journal of environmental research and public health, 2015. DOI:10.3390/ijerph120505215
Flavoring Chemicals in E-Cigarettes: Diacetyl, 2,3-Pentanedione, and Acetoin in a Sample of 51 Products, Including Fruit-, Candy-, and Cocktail-Flavored E-Cigarettes. Allen GJ, Flanigan SS et al. Environmental Health Perspectives, 2016. DOI:10.1289/ehp.1510185
Evaluation of Flavorings-Related Lung Disease Risk at Six Microwave Popcorn Plants. Kanwal R, Kullman G et al. Journal of Occupational & Environmental Medicine, 2006. DOI:10.1097/01.jom.0000194152.48728.fb
Determination of toxic carbonyl compounds in cigarette smoke. Fujioka K, Shibamoto T. Environmental toxicology, 2006. PMID:16463255
Diacetyl and 2,3-pentanedione exposures associated with cigarette smoking: implications for risk assessment of food and flavoring workers. Pierce JS, Abelmann A et al. Critical reviews in toxicology, 2014. PMID:24635357
Evaluation of pulmonary function within a cohort of flavorings workers. Ronk CJ, Hollins DM et al. Inhalation toxicology, 2013. PMID:23363043